2010-020729-42: A study to determine the safety of a new drug to treat non-squamous non-small cell lung cancer |
|
|
| Not yet recruiting | 1/2 | 74 | Europe | Lyophilised L-DOS47, L-DOS47, Lyophilisate for solution for infusion | Helix BioPharma Corp, Helix BioPharma Corp. | Inoperable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer, Non-squamous non-small cell lung cancer that cannot be operated on, is locally advanced, has spread to other areas of the body or has returned after previous treatment., Diseases [C] - Cancer [C04] | | | | |
